Global Anthrax Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anthrax Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anthrax Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anthrax Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Anthrax Vaccines Segment by Type

2.2.1 Live Vaccines

2.2.2 Cell free PA Vaccines

2.3 Anthrax Vaccines Sales by Type

2.3.1 Global Anthrax Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anthrax Vaccines Sale Price by Type (2017-2022)

2.4 Anthrax Vaccines Segment by Application

2.4.1 Human Use

2.4.2 Animal Use

2.5 Anthrax Vaccines Sales by Application

2.5.1 Global Anthrax Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Anthrax Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anthrax Vaccines Sale Price by Application (2017-2022)

3 Global Anthrax Vaccines by Company

3.1 Global Anthrax Vaccines Breakdown Data by Company

3.1.1 Global Anthrax Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Anthrax Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Anthrax Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Anthrax Vaccines Revenue by Company (2020-2022)

3.2.2 Global Anthrax Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Anthrax Vaccines Sale Price by Company

3.4 Key Manufacturers Anthrax Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anthrax Vaccines Product Location Distribution

3.4.2 Players Anthrax Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anthrax Vaccines by Geographic Region

4.1 World Historic Anthrax Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Anthrax Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anthrax Vaccines Annual Revenue by Geographic Region

4.2 World Historic Anthrax Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Anthrax Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anthrax Vaccines Annual Revenue by Country/Region

4.3 Americas Anthrax Vaccines Sales Growth

4.4 APAC Anthrax Vaccines Sales Growth

4.5 Europe Anthrax Vaccines Sales Growth

4.6 Middle East & Africa Anthrax Vaccines Sales Growth

5 Americas

5.1 Americas Anthrax Vaccines Sales by Country

5.1.1 Americas Anthrax Vaccines Sales by Country (2017-2022)

5.1.2 Americas Anthrax Vaccines Revenue by Country (2017-2022)

5.2 Americas Anthrax Vaccines Sales by Type

5.3 Americas Anthrax Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anthrax Vaccines Sales by Region

6.1.1 APAC Anthrax Vaccines Sales by Region (2017-2022)

6.1.2 APAC Anthrax Vaccines Revenue by Region (2017-2022)

6.2 APAC Anthrax Vaccines Sales by Type

6.3 APAC Anthrax Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anthrax Vaccines by Country

7.1.1 Europe Anthrax Vaccines Sales by Country (2017-2022)

7.1.2 Europe Anthrax Vaccines Revenue by Country (2017-2022)

7.2 Europe Anthrax Vaccines Sales by Type

7.3 Europe Anthrax Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anthrax Vaccines by Country

8.1.1 Middle East & Africa Anthrax Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anthrax Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Anthrax Vaccines Sales by Type

8.3 Middle East & Africa Anthrax Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anthrax Vaccines

10.3 Manufacturing Process Analysis of Anthrax Vaccines

10.4 Industry Chain Structure of Anthrax Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anthrax Vaccines Distributors

11.3 Anthrax Vaccines Customer

12 World Forecast Review for Anthrax Vaccines by Geographic Region

12.1 Global Anthrax Vaccines Market Size Forecast by Region

12.1.1 Global Anthrax Vaccines Forecast by Region (2023-2028)

12.1.2 Global Anthrax Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anthrax Vaccines Forecast by Type

12.7 Global Anthrax Vaccines Forecast by Application

13 Key Players Analysis

13.1 Emergent BioSolutions

13.1.1 Emergent BioSolutions Company Information

13.1.2 Emergent BioSolutions Anthrax Vaccines Product Offered

13.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Emergent BioSolutions Main Business Overview

13.1.5 Emergent BioSolutions Latest Developments

13.2 Merial

13.2.1 Merial Company Information

13.2.2 Merial Anthrax Vaccines Product Offered

13.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merial Main Business Overview

13.2.5 Merial Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Anthrax Vaccines Product Offered

13.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Zoetis

13.4.1 Zoetis Company Information

13.4.2 Zoetis Anthrax Vaccines Product Offered

13.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Zoetis Main Business Overview

13.4.5 Zoetis Latest Developments

13.5 Bayer Sanidad Animal

13.5.1 Bayer Sanidad Animal Company Information

13.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Offered

13.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Sanidad Animal Main Business Overview

13.5.5 Bayer Sanidad Animal Latest Developments

13.6 Colorado Serum

13.6.1 Colorado Serum Company Information

13.6.2 Colorado Serum Anthrax Vaccines Product Offered

13.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Colorado Serum Main Business Overview

13.6.5 Colorado Serum Latest Developments

13.7 PharmAthene

13.7.1 PharmAthene Company Information

13.7.2 PharmAthene Anthrax Vaccines Product Offered

13.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 PharmAthene Main Business Overview

13.7.5 PharmAthene Latest Developments

13.8 Tiankang

13.8.1 Tiankang Company Information

13.8.2 Tiankang Anthrax Vaccines Product Offered

13.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Tiankang Main Business Overview

13.8.5 Tiankang Latest Developments

13.9 Biogénesis-Bago

13.9.1 Biogénesis-Bago Company Information

13.9.2 Biogénesis-Bago Anthrax Vaccines Product Offered

13.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biogénesis-Bago Main Business Overview

13.9.5 Biogénesis-Bago Latest Developments

13.10 CAVAC

13.10.1 CAVAC Company Information

13.10.2 CAVAC Anthrax Vaccines Product Offered

13.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CAVAC Main Business Overview

13.10.5 CAVAC Latest Developments

13.11 Rosenbusch

13.11.1 Rosenbusch Company Information

13.11.2 Rosenbusch Anthrax Vaccines Product Offered

13.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Rosenbusch Main Business Overview

13.11.5 Rosenbusch Latest Developments

13.12 Agrovet

13.12.1 Agrovet Company Information

13.12.2 Agrovet Anthrax Vaccines Product Offered

13.12.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Agrovet Main Business Overview

13.12.5 Agrovet Latest Developments

13.13 Vecol

13.13.1 Vecol Company Information

13.13.2 Vecol Anthrax Vaccines Product Offered

13.13.3 Vecol Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Vecol Main Business Overview

13.13.5 Vecol Latest Developments

13.14 CVCRI

13.14.1 CVCRI Company Information

13.14.2 CVCRI Anthrax Vaccines Product Offered

13.14.3 CVCRI Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 CVCRI Main Business Overview

13.14.5 CVCRI Latest Developments

13.15 IVPM

13.15.1 IVPM Company Information

13.15.2 IVPM Anthrax Vaccines Product Offered

13.15.3 IVPM Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 IVPM Main Business Overview

13.15.5 IVPM Latest Developments

13.16 Prondil

13.16.1 Prondil Company Information

13.16.2 Prondil Anthrax Vaccines Product Offered

13.16.3 Prondil Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Prondil Main Business Overview

13.16.5 Prondil Latest Developments

13.17 CDV

13.17.1 CDV Company Information

13.17.2 CDV Anthrax Vaccines Product Offered

13.17.3 CDV Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 CDV Main Business Overview

13.17.5 CDV Latest Developments

13.18 Indian Immunologicals

13.18.1 Indian Immunologicals Company Information

13.18.2 Indian Immunologicals Anthrax Vaccines Product Offered

13.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Indian Immunologicals Main Business Overview

13.18.5 Indian Immunologicals Latest Developments

13.19 Botswana Vaccine Institute

13.19.1 Botswana Vaccine Institute Company Information

13.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Offered

13.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Botswana Vaccine Institute Main Business Overview

13.19.5 Botswana Vaccine Institute Latest Developments

13.20 Ceva Santé Animale

13.20.1 Ceva Santé Animale Company Information

13.20.2 Ceva Santé Animale Anthrax Vaccines Product Offered

13.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Ceva Santé Animale Main Business Overview

13.20.5 Ceva Santé Animale Latest Developments

13.21 Intervac

13.21.1 Intervac Company Information

13.21.2 Intervac Anthrax Vaccines Product Offered

13.21.3 Intervac Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Intervac Main Business Overview

13.21.5 Intervac Latest Developments

13.22 JOVAC

13.22.1 JOVAC Company Information

13.22.2 JOVAC Anthrax Vaccines Product Offered

13.22.3 JOVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 JOVAC Main Business Overview

13.22.5 JOVAC Latest Developments

14 Research Findings and Conclusion

Table 1. Anthrax Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anthrax Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Vaccines

Table 4. Major Players of Cell free PA Vaccines

Table 5. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 6. Global Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Anthrax Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anthrax Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Anthrax Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 10. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 11. Global Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Anthrax Vaccines Revenue by Application (2017-2022)

Table 13. Global Anthrax Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Anthrax Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 15. Global Anthrax Vaccines Sales by Company (2020-2022) & (M Doses)

Table 16. Global Anthrax Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Anthrax Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anthrax Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Anthrax Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 20. Key Manufacturers Anthrax Vaccines Producing Area Distribution and Sales Area

Table 21. Players Anthrax Vaccines Products Offered

Table 22. Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anthrax Vaccines Sales by Geographic Region (2017-2022) & (M Doses)

Table 26. Global Anthrax Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anthrax Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anthrax Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anthrax Vaccines Sales by Country/Region (2017-2022) & (M Doses)

Table 30. Global Anthrax Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anthrax Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anthrax Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 34. Americas Anthrax Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anthrax Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 38. Americas Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 40. Americas Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)

Table 42. APAC Anthrax Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Anthrax Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anthrax Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 46. APAC Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 48. APAC Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 50. Europe Anthrax Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anthrax Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 54. Europe Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 56. Europe Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 58. Middle East & Africa Anthrax Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 62. Middle East & Africa Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 64. Middle East & Africa Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anthrax Vaccines

Table 66. Key Market Challenges & Risks of Anthrax Vaccines

Table 67. Key Industry Trends of Anthrax Vaccines

Table 68. Anthrax Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anthrax Vaccines Distributors List

Table 71. Anthrax Vaccines Customer List

Table 72. Global Anthrax Vaccines Sales Forecast by Region (2023-2028) & (M Doses)

Table 73. Global Anthrax Vaccines Sales Market Forecast by Region

Table 74. Global Anthrax Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anthrax Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anthrax Vaccines Sales Forecast by Country (2023-2028) & (M Doses)

Table 77. Americas Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anthrax Vaccines Sales Forecast by Region (2023-2028) & (M Doses)

Table 79. APAC Anthrax Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anthrax Vaccines Sales Forecast by Country (2023-2028) & (M Doses)

Table 81. Europe Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anthrax Vaccines Sales Forecast by Country (2023-2028) & (M Doses)

Table 83. Middle East & Africa Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anthrax Vaccines Sales Forecast by Type (2023-2028) & (M Doses)

Table 85. Global Anthrax Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anthrax Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anthrax Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anthrax Vaccines Sales Forecast by Application (2023-2028) & (M Doses)

Table 89. Global Anthrax Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anthrax Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anthrax Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Emergent BioSolutions Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Emergent BioSolutions Anthrax Vaccines Product Offered

Table 94. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 95. Emergent BioSolutions Main Business

Table 96. Emergent BioSolutions Latest Developments

Table 97. Merial Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Merial Anthrax Vaccines Product Offered

Table 99. Merial Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 100. Merial Main Business

Table 101. Merial Latest Developments

Table 102. Merck Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Merck Anthrax Vaccines Product Offered

Table 104. Merck Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 105. Merck Main Business

Table 106. Merck Latest Developments

Table 107. Zoetis Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Zoetis Anthrax Vaccines Product Offered

Table 109. Zoetis Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 110. Zoetis Main Business

Table 111. Zoetis Latest Developments

Table 112. Bayer Sanidad Animal Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Bayer Sanidad Animal Anthrax Vaccines Product Offered

Table 114. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 115. Bayer Sanidad Animal Main Business

Table 116. Bayer Sanidad Animal Latest Developments

Table 117. Colorado Serum Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Colorado Serum Anthrax Vaccines Product Offered

Table 119. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 120. Colorado Serum Main Business

Table 121. Colorado Serum Latest Developments

Table 122. PharmAthene Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. PharmAthene Anthrax Vaccines Product Offered

Table 124. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 125. PharmAthene Main Business

Table 126. PharmAthene Latest Developments

Table 127. Tiankang Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Tiankang Anthrax Vaccines Product Offered

Table 129. Tiankang Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 130. Tiankang Main Business

Table 131. Tiankang Latest Developments

Table 132. Biogénesis-Bago Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Biogénesis-Bago Anthrax Vaccines Product Offered

Table 134. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 135. Biogénesis-Bago Main Business

Table 136. Biogénesis-Bago Latest Developments

Table 137. CAVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. CAVAC Anthrax Vaccines Product Offered

Table 139. CAVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 140. CAVAC Main Business

Table 141. CAVAC Latest Developments

Table 142. Rosenbusch Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Rosenbusch Anthrax Vaccines Product Offered

Table 144. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 145. Rosenbusch Main Business

Table 146. Rosenbusch Latest Developments

Table 147. Agrovet Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Agrovet Anthrax Vaccines Product Offered

Table 149. Agrovet Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 150. Agrovet Main Business

Table 151. Agrovet Latest Developments

Table 152. Vecol Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. Vecol Anthrax Vaccines Product Offered

Table 154. Vecol Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 155. Vecol Main Business

Table 156. Vecol Latest Developments

Table 157. CVCRI Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. CVCRI Anthrax Vaccines Product Offered

Table 159. CVCRI Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 160. CVCRI Main Business

Table 161. CVCRI Latest Developments

Table 162. IVPM Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. IVPM Anthrax Vaccines Product Offered

Table 164. IVPM Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 165. IVPM Main Business

Table 166. IVPM Latest Developments

Table 167. Prondil Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. Prondil Anthrax Vaccines Product Offered

Table 169. Prondil Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 170. Prondil Main Business

Table 171. Prondil Latest Developments

Table 172. CDV Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 173. CDV Anthrax Vaccines Product Offered

Table 174. CDV Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 175. CDV Main Business

Table 176. CDV Latest Developments

Table 177. Indian Immunologicals Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 178. Indian Immunologicals Anthrax Vaccines Product Offered

Table 179. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 180. Indian Immunologicals Main Business

Table 181. Indian Immunologicals Latest Developments

Table 182. Botswana Vaccine Institute Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 183. Botswana Vaccine Institute Anthrax Vaccines Product Offered

Table 184. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 185. Botswana Vaccine Institute Main Business

Table 186. Botswana Vaccine Institute Latest Developments

Table 187. Ceva Santé Animale Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 188. Ceva Santé Animale Anthrax Vaccines Product Offered

Table 189. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 190. Ceva Santé Animale Main Business

Table 191. Ceva Santé Animale Latest Developments

Table 192. Intervac Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 193. Intervac Anthrax Vaccines Product Offered

Table 194. Intervac Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 195. Intervac Main Business

Table 196. Intervac Latest Developments

Table 197. JOVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 198. JOVAC Anthrax Vaccines Product Offered

Table 199. JOVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 200. JOVAC Main Business

Table 201. JOVAC Latest Developments

List of Figures

Figure 1. Picture of Anthrax Vaccines

Figure 2. Anthrax Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anthrax Vaccines Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Anthrax Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anthrax Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Vaccines

Figure 10. Product Picture of Cell free PA Vaccines

Figure 11. Global Anthrax Vaccines Sales Market Share by Type in 2021

Figure 12. Global Anthrax Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Anthrax Vaccines Consumed in Human Use

Figure 14. Global Anthrax Vaccines Market: Human Use (2017-2022) & (M Doses)

Figure 15. Anthrax Vaccines Consumed in Animal Use

Figure 16. Global Anthrax Vaccines Market: Animal Use (2017-2022) & (M Doses)

Figure 17. Global Anthrax Vaccines Sales Market Share by Application (2017-2022)

Figure 18. Global Anthrax Vaccines Revenue Market Share by Application in 2021

Figure 19. Anthrax Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Anthrax Vaccines Revenue Market Share by Company in 2021

Figure 21. Global Anthrax Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Anthrax Vaccines Revenue Market Share by Geographic Region in 2021

Figure 23. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)

Figure 24. Global Anthrax Vaccines Revenue Market Share by Country/Region in 2021

Figure 25. Americas Anthrax Vaccines Sales 2017-2022 (M Doses)

Figure 26. Americas Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 27. APAC Anthrax Vaccines Sales 2017-2022 (M Doses)

Figure 28. APAC Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. Europe Anthrax Vaccines Sales 2017-2022 (M Doses)

Figure 30. Europe Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Anthrax Vaccines Sales 2017-2022 (M Doses)

Figure 32. Middle East & Africa Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Americas Anthrax Vaccines Sales Market Share by Country in 2021

Figure 34. Americas Anthrax Vaccines Revenue Market Share by Country in 2021

Figure 35. United States Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Anthrax Vaccines Sales Market Share by Region in 2021

Figure 40. APAC Anthrax Vaccines Revenue Market Share by Regions in 2021

Figure 41. China Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Anthrax Vaccines Sales Market Share by Country in 2021

Figure 48. Europe Anthrax Vaccines Revenue Market Share by Country in 2021

Figure 49. Germany Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Anthrax Vaccines Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country in 2021

Figure 56. Egypt Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Anthrax Vaccines in 2021

Figure 62. Manufacturing Process Analysis of Anthrax Vaccines

Figure 63. Industry Chain Structure of Anthrax Vaccines

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles